Oncology
Metastatic Breast Cancer
Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at SABCS 2026
Overview
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Metastatic Breast Cancer presented at the San Antonio Breast Cancer Symposium 2026.
VIEW THE TOPICS:
- After CDK4/6 Inhibition: Which Biomarkers Should Guide the Next Treatment Choice for HR+/HER2- Metastatic Breast Cancer?
- Extending Overall Survival in HR+/HER2- Advanced Breast Cancer
- PI3K Pathway Targeting and Implications for the Treatment of HR+/HER2- Metastatic Breast Cancer
This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the San Antonio Breast Cancer Symposium.
SABCS 2026
December 8 – December 11, 2026
Henry B. Gonzalez Convention Center
San Antonio, TX



